InsidersTradesSigma
Follow the MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED stock price and the full management transaction log of the company, a publicly traded company based in Australia. Shares are listed on the AU market, under the supervision of ASX. Market capitalisation: €53.5m. The latest transaction was disclosed on 3 June 2026 (Initial Substantial Holding). Among the most active insiders: NFPFRN (if applicable). All data is free.
Analysts rate MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED Strong Buy (bullish), based on 2 analysts. Average price target: A$2.29.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Medical Developments International Limited 是一家澳大利亚公司，专注于开发医疗产品，特别是疼痛管理设备。该公司在澳大利亚证券交易所上市，股票代码为 XASX。